These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17431122)
1. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Ben-Shoshan M; Amir S; Dang DT; Dang LH; Weisman Y; Mabjeesh NJ Mol Cancer Ther; 2007 Apr; 6(4):1433-9. PubMed ID: 17431122 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer. Zhu H; Zhang S J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944 [TBL] [Abstract][Full Text] [Related]
3. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804 [TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane inhibits hypoxia-induced HIF-1α and VEGF expression and migration of human colon cancer cells. Kim DH; Sung B; Kang YJ; Hwang SY; Kim MJ; Yoon JH; Im E; Kim ND Int J Oncol; 2015 Dec; 47(6):2226-32. PubMed ID: 26498863 [TBL] [Abstract][Full Text] [Related]
8. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha. Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007 [TBL] [Abstract][Full Text] [Related]
9. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer. Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394 [TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. Tammali R; Saxena A; Srivastava SK; Ramana KV J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240 [TBL] [Abstract][Full Text] [Related]
11. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
12. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
13. Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner. Jo JO; Kim SR; Bae MK; Kang YJ; Ock MS; Kleinman HK; Cha HJ Biochim Biophys Acta; 2010 Nov; 1803(11):1244-51. PubMed ID: 20691219 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells. Sun YZ; Cai N; Liu NN Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640 [TBL] [Abstract][Full Text] [Related]
15. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546 [TBL] [Abstract][Full Text] [Related]
16. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer. Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564 [TBL] [Abstract][Full Text] [Related]
17. Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Fu B; Xue J; Li Z; Shi X; Jiang BH; Fang J Mol Cancer Ther; 2007 Jan; 6(1):220-6. PubMed ID: 17237281 [TBL] [Abstract][Full Text] [Related]
18. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Alqawi O; Moghaddas M; Singh G Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534 [TBL] [Abstract][Full Text] [Related]
19. Role of vincristine in the inhibition of angiogenesis in glioblastoma. Park KJ; Yu MO; Park DH; Park JY; Chung YG; Kang SH Neurol Res; 2016 Oct; 38(10):871-9. PubMed ID: 27472259 [TBL] [Abstract][Full Text] [Related]
20. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells. Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]